Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma

The aim of the present study was to compare the efficacy of a novel phosphodiesterase 4 and 5 inhibitor, LASSBio596, with that of dexamethasone in a murine model of chronic asthma. Lung mechanics (airway resistance, viscoelastic pressure, and static elastance), histology, and airway and lung parench...

Full description

Bibliographic Details
Main Authors: Campos H.S., Xisto D.G., Oliveira M.B.G., Teixeira I., Negri E.M., Mauad T., Carnielli D., Lima L.M., Barreiro E.J., Faffe D.S., Zin W.A., Lapa e Silva J.R., Rocco P.R.M.
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2006-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000200016
_version_ 1818022380612616192
author Campos H.S.
Xisto D.G.
Oliveira M.B.G.
Teixeira I.
Negri E.M.
Mauad T.
Carnielli D.
Lima L.M.
Barreiro E.J.
Faffe D.S.
Zin W.A.
Lapa e Silva J.R.
Rocco P.R.M.
author_facet Campos H.S.
Xisto D.G.
Oliveira M.B.G.
Teixeira I.
Negri E.M.
Mauad T.
Carnielli D.
Lima L.M.
Barreiro E.J.
Faffe D.S.
Zin W.A.
Lapa e Silva J.R.
Rocco P.R.M.
author_sort Campos H.S.
collection DOAJ
description The aim of the present study was to compare the efficacy of a novel phosphodiesterase 4 and 5 inhibitor, LASSBio596, with that of dexamethasone in a murine model of chronic asthma. Lung mechanics (airway resistance, viscoelastic pressure, and static elastance), histology, and airway and lung parenchyma remodeling (quantitative analysis of collagen and elastic fiber) were analyzed. Thirty-three BALB/c mice were randomly assigned to four groups. In the asthma group (N = 9), mice were immunized with 10 µg ovalbumin (OVA, ip) on 7 alternate days, and after day 40 they were challenged with three intratracheal instillations of 20 µg OVA at 3-day intervals. Control mice (N = 8) received saline under the same protocol. In the dexamethasone (N = 8) and LASSBio596 (N = 8) groups, the animals of the asthma group were treated with 1 mg/kg dexamethasone disodium phosphate (0.1 mL, ip) or 10 mg/kg LASSBio596 dissolved in dimethyl sulfoxide (0.2 mL, ip) 24 h before the first intratracheal instillation of OVA, for 8 days. Airway resistance, viscoelastic pressure and static elastance increased significantly in the asthma group (77, 56, and 76%, respectively) compared to the control group. The asthma group presented more intense alveolar collapse, bronchoconstriction, and eosinophil and neutrophil infiltration than the control group. Both LASSBio596 and dexamethasone inhibited the changes in lung mechanics, tissue cellularity, bronchoconstriction, as well as airway and lung parenchyma remodeling. In conclusion, LASSBio596 at a dose of 10 mg/kg effectively prevented lung mechanical and morphometrical changes and had the potential to block fibroproliferation in a BALB/c mouse model of asthma.
first_indexed 2024-04-14T08:31:48Z
format Article
id doaj.art-077a3d70bd16487a878374edddaf4505
institution Directory Open Access Journal
issn 0100-879X
0034-7310
language English
last_indexed 2024-04-14T08:31:48Z
publishDate 2006-01-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-077a3d70bd16487a878374edddaf45052022-12-22T02:03:54ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X0034-73102006-01-01392283287Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthmaCampos H.S.Xisto D.G.Oliveira M.B.G.Teixeira I.Negri E.M.Mauad T.Carnielli D.Lima L.M.Barreiro E.J.Faffe D.S.Zin W.A.Lapa e Silva J.R.Rocco P.R.M.The aim of the present study was to compare the efficacy of a novel phosphodiesterase 4 and 5 inhibitor, LASSBio596, with that of dexamethasone in a murine model of chronic asthma. Lung mechanics (airway resistance, viscoelastic pressure, and static elastance), histology, and airway and lung parenchyma remodeling (quantitative analysis of collagen and elastic fiber) were analyzed. Thirty-three BALB/c mice were randomly assigned to four groups. In the asthma group (N = 9), mice were immunized with 10 µg ovalbumin (OVA, ip) on 7 alternate days, and after day 40 they were challenged with three intratracheal instillations of 20 µg OVA at 3-day intervals. Control mice (N = 8) received saline under the same protocol. In the dexamethasone (N = 8) and LASSBio596 (N = 8) groups, the animals of the asthma group were treated with 1 mg/kg dexamethasone disodium phosphate (0.1 mL, ip) or 10 mg/kg LASSBio596 dissolved in dimethyl sulfoxide (0.2 mL, ip) 24 h before the first intratracheal instillation of OVA, for 8 days. Airway resistance, viscoelastic pressure and static elastance increased significantly in the asthma group (77, 56, and 76%, respectively) compared to the control group. The asthma group presented more intense alveolar collapse, bronchoconstriction, and eosinophil and neutrophil infiltration than the control group. Both LASSBio596 and dexamethasone inhibited the changes in lung mechanics, tissue cellularity, bronchoconstriction, as well as airway and lung parenchyma remodeling. In conclusion, LASSBio596 at a dose of 10 mg/kg effectively prevented lung mechanical and morphometrical changes and had the potential to block fibroproliferation in a BALB/c mouse model of asthma.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000200016AsthmaLung functionSteroidPhosphodiesterase inhibitorsBALB/c mice
spellingShingle Campos H.S.
Xisto D.G.
Oliveira M.B.G.
Teixeira I.
Negri E.M.
Mauad T.
Carnielli D.
Lima L.M.
Barreiro E.J.
Faffe D.S.
Zin W.A.
Lapa e Silva J.R.
Rocco P.R.M.
Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma
Brazilian Journal of Medical and Biological Research
Asthma
Lung function
Steroid
Phosphodiesterase inhibitors
BALB/c mice
title Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma
title_full Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma
title_fullStr Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma
title_full_unstemmed Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma
title_short Protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma
title_sort protective effects of phosphodiesterase inhibitors on lung function and remodeling in a murine model of chronic asthma
topic Asthma
Lung function
Steroid
Phosphodiesterase inhibitors
BALB/c mice
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2006000200016
work_keys_str_mv AT camposhs protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT xistodg protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT oliveirambg protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT teixeirai protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT negriem protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT mauadt protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT carniellid protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT limalm protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT barreiroej protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT faffeds protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT zinwa protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT lapaesilvajr protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma
AT roccoprm protectiveeffectsofphosphodiesteraseinhibitorsonlungfunctionandremodelinginamurinemodelofchronicasthma